世界のウィルソン病治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Wilson's Disease Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-6072 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、ウィルソン病治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（肝臓、神経精神科、眼科、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・ウィルソン病治療薬の市場動向 ・企業の競争状況、市場シェア ・ウィルソン病治療薬の種類別市場規模と予測2016-2027（肝臓、神経精神科、眼科、その他） ・ウィルソン病治療薬の用途別市場規模と予測2016-2027（病院、クリニック、その他） ・ウィルソン病治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・ウィルソン病治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・ウィルソン病治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ウィルソン病治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・ウィルソン病治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Kadmon Holdings, Inc.、Merck & Co.、Teva Pharmaceutical Industries Limited、Tsumura & Co.、Valeant Pharmaceuticals International, Inc.、VHB Life Sciences, Inc.、Wilson Therapeutics AB (Alexion)） ・結論

Wilson’s Disease Drugs are used to reduce excessive copper in serum, indirectly reducing the accumulation of copper in various tissues of the body.

Market Analysis and Insights: Global Wilson’s Disease Drugs Market
The global Wilson’s Disease Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Wilson’s Disease Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Wilson’s Disease Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Wilson’s Disease Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Wilson’s Disease Drugs market.

Global Wilson’s Disease Drugs Scope and Market Size
Wilson’s Disease Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Wilson’s Disease Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Hepatic
Neuropsychiatric
Ophthalmic
Others

Segment by Application
Hospitals
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Kadmon Holdings, Inc.
Merck & Co.
Teva Pharmaceutical Industries Limited
Tsumura & Co.
Valeant Pharmaceuticals International, Inc.
VHB Life Sciences, Inc.
Wilson Therapeutics AB (Alexion)

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Wilson’s Disease Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Hepatic
1.2.3 Neuropsychiatric
1.2.4 Ophthalmic
1.2.5 Others
1.3 Market by Application
1.3.1 Global Wilson’s Disease Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Wilson’s Disease Drugs Market Perspective (2016-2027)
2.2 Wilson’s Disease Drugs Growth Trends by Regions
2.2.1 Wilson’s Disease Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Wilson’s Disease Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Wilson’s Disease Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Wilson’s Disease Drugs Industry Dynamic
2.3.1 Wilson’s Disease Drugs Market Trends
2.3.2 Wilson’s Disease Drugs Market Drivers
2.3.3 Wilson’s Disease Drugs Market Challenges
2.3.4 Wilson’s Disease Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Wilson’s Disease Drugs Players by Revenue
3.1.1 Global Top Wilson’s Disease Drugs Players by Revenue (2016-2021)
3.1.2 Global Wilson’s Disease Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Wilson’s Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Wilson’s Disease Drugs Revenue
3.4 Global Wilson’s Disease Drugs Market Concentration Ratio
3.4.1 Global Wilson’s Disease Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Wilson’s Disease Drugs Revenue in 2020
3.5 Wilson’s Disease Drugs Key Players Head office and Area Served
3.6 Key Players Wilson’s Disease Drugs Product Solution and Service
3.7 Date of Enter into Wilson’s Disease Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Wilson’s Disease Drugs Breakdown Data by Type
4.1 Global Wilson’s Disease Drugs Historic Market Size by Type (2016-2021)
4.2 Global Wilson’s Disease Drugs Forecasted Market Size by Type (2022-2027)

5 Wilson’s Disease Drugs Breakdown Data by Application
5.1 Global Wilson’s Disease Drugs Historic Market Size by Application (2016-2021)
5.2 Global Wilson’s Disease Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Wilson’s Disease Drugs Market Size (2016-2027)
6.2 North America Wilson’s Disease Drugs Market Size by Type
6.2.1 North America Wilson’s Disease Drugs Market Size by Type (2016-2021)
6.2.2 North America Wilson’s Disease Drugs Market Size by Type (2022-2027)
6.2.3 North America Wilson’s Disease Drugs Market Size by Type (2016-2027)
6.3 North America Wilson’s Disease Drugs Market Size by Application
6.3.1 North America Wilson’s Disease Drugs Market Size by Application (2016-2021)
6.3.2 North America Wilson’s Disease Drugs Market Size by Application (2022-2027)
6.3.3 North America Wilson’s Disease Drugs Market Size by Application (2016-2027)
6.4 North America Wilson’s Disease Drugs Market Size by Country
6.4.1 North America Wilson’s Disease Drugs Market Size by Country (2016-2021)
6.4.2 North America Wilson’s Disease Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Wilson’s Disease Drugs Market Size (2016-2027)
7.2 Europe Wilson’s Disease Drugs Market Size by Type
7.2.1 Europe Wilson’s Disease Drugs Market Size by Type (2016-2021)
7.2.2 Europe Wilson’s Disease Drugs Market Size by Type (2022-2027)
7.2.3 Europe Wilson’s Disease Drugs Market Size by Type (2016-2027)
7.3 Europe Wilson’s Disease Drugs Market Size by Application
7.3.1 Europe Wilson’s Disease Drugs Market Size by Application (2016-2021)
7.3.2 Europe Wilson’s Disease Drugs Market Size by Application (2022-2027)
7.3.3 Europe Wilson’s Disease Drugs Market Size by Application (2016-2027)
7.4 Europe Wilson’s Disease Drugs Market Size by Country
7.4.1 Europe Wilson’s Disease Drugs Market Size by Country (2016-2021)
7.4.2 Europe Wilson’s Disease Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Wilson’s Disease Drugs Market Size (2016-2027)
8.2 Asia-Pacific Wilson’s Disease Drugs Market Size by Type
8.2.1 Asia-Pacific Wilson’s Disease Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Wilson’s Disease Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Wilson’s Disease Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Wilson’s Disease Drugs Market Size by Application
8.3.1 Asia-Pacific Wilson’s Disease Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Wilson’s Disease Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Wilson’s Disease Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Wilson’s Disease Drugs Market Size by Region
8.4.1 Asia-Pacific Wilson’s Disease Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Wilson’s Disease Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Wilson’s Disease Drugs Market Size (2016-2027)
9.2 Latin America Wilson’s Disease Drugs Market Size by Type
9.2.1 Latin America Wilson’s Disease Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Wilson’s Disease Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Wilson’s Disease Drugs Market Size by Type (2016-2027)
9.3 Latin America Wilson’s Disease Drugs Market Size by Application
9.3.1 Latin America Wilson’s Disease Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Wilson’s Disease Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Wilson’s Disease Drugs Market Size by Application (2016-2027)
9.4 Latin America Wilson’s Disease Drugs Market Size by Country
9.4.1 Latin America Wilson’s Disease Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Wilson’s Disease Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Wilson’s Disease Drugs Market Size (2016-2027)
10.2 Middle East & Africa Wilson’s Disease Drugs Market Size by Type
10.2.1 Middle East & Africa Wilson’s Disease Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Wilson’s Disease Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Wilson’s Disease Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Wilson’s Disease Drugs Market Size by Application
10.3.1 Middle East & Africa Wilson’s Disease Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Wilson’s Disease Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Wilson’s Disease Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Wilson’s Disease Drugs Market Size by Country
10.4.1 Middle East & Africa Wilson’s Disease Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Wilson’s Disease Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Kadmon Holdings, Inc.
11.1.1 Kadmon Holdings, Inc. Company Details
11.1.2 Kadmon Holdings, Inc. Business Overview
11.1.3 Kadmon Holdings, Inc. Wilson’s Disease Drugs Introduction
11.1.4 Kadmon Holdings, Inc. Revenue in Wilson’s Disease Drugs Business (2016-2021)
11.1.5 Kadmon Holdings, Inc. Recent Development
11.2 Merck & Co.
11.2.1 Merck & Co. Company Details
11.2.2 Merck & Co. Business Overview
11.2.3 Merck & Co. Wilson’s Disease Drugs Introduction
11.2.4 Merck & Co. Revenue in Wilson’s Disease Drugs Business (2016-2021)
11.2.5 Merck & Co. Recent Development
11.3 Teva Pharmaceutical Industries Limited
11.3.1 Teva Pharmaceutical Industries Limited Company Details
11.3.2 Teva Pharmaceutical Industries Limited Business Overview
11.3.3 Teva Pharmaceutical Industries Limited Wilson’s Disease Drugs Introduction
11.3.4 Teva Pharmaceutical Industries Limited Revenue in Wilson’s Disease Drugs Business (2016-2021)
11.3.5 Teva Pharmaceutical Industries Limited Recent Development
11.4 Tsumura & Co.
11.4.1 Tsumura & Co. Company Details
11.4.2 Tsumura & Co. Business Overview
11.4.3 Tsumura & Co. Wilson’s Disease Drugs Introduction
11.4.4 Tsumura & Co. Revenue in Wilson’s Disease Drugs Business (2016-2021)
11.4.5 Tsumura & Co. Recent Development
11.5 Valeant Pharmaceuticals International, Inc.
11.5.1 Valeant Pharmaceuticals International, Inc. Company Details
11.5.2 Valeant Pharmaceuticals International, Inc. Business Overview
11.5.3 Valeant Pharmaceuticals International, Inc. Wilson’s Disease Drugs Introduction
11.5.4 Valeant Pharmaceuticals International, Inc. Revenue in Wilson’s Disease Drugs Business (2016-2021)
11.5.5 Valeant Pharmaceuticals International, Inc. Recent Development
11.6 VHB Life Sciences, Inc.
11.6.1 VHB Life Sciences, Inc. Company Details
11.6.2 VHB Life Sciences, Inc. Business Overview
11.6.3 VHB Life Sciences, Inc. Wilson’s Disease Drugs Introduction
11.6.4 VHB Life Sciences, Inc. Revenue in Wilson’s Disease Drugs Business (2016-2021)
11.6.5 VHB Life Sciences, Inc. Recent Development
11.7 Wilson Therapeutics AB (Alexion)
11.7.1 Wilson Therapeutics AB (Alexion) Company Details
11.7.2 Wilson Therapeutics AB (Alexion) Business Overview
11.7.3 Wilson Therapeutics AB (Alexion) Wilson’s Disease Drugs Introduction
11.7.4 Wilson Therapeutics AB (Alexion) Revenue in Wilson’s Disease Drugs Business (2016-2021)
11.7.5 Wilson Therapeutics AB (Alexion) Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Wilson's Disease Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Hepatic
Table 3. Key Players of Neuropsychiatric
Table 4. Key Players of Ophthalmic
Table 5. Key Players of Others
Table 6. Global Wilson's Disease Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Wilson's Disease Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Wilson's Disease Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Wilson's Disease Drugs Market Share by Regions (2016-2021)
Table 10. Global Wilson's Disease Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Wilson's Disease Drugs Market Share by Regions (2022-2027)
Table 12. Wilson's Disease Drugs Market Trends
Table 13. Wilson's Disease Drugs Market Drivers
Table 14. Wilson's Disease Drugs Market Challenges
Table 15. Wilson's Disease Drugs Market Restraints
Table 16. Global Wilson's Disease Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Wilson's Disease Drugs Market Share by Players (2016-2021)
Table 18. Global Top Wilson's Disease Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Wilson's Disease Drugs as of 2020)
Table 19. Ranking of Global Top Wilson's Disease Drugs Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Wilson's Disease Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Wilson's Disease Drugs Product Solution and Service
Table 23. Date of Enter into Wilson's Disease Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Wilson's Disease Drugs Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Wilson's Disease Drugs Revenue Market Share by Type (2016-2021)
Table 27. Global Wilson's Disease Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Wilson's Disease Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Wilson's Disease Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Wilson's Disease Drugs Revenue Market Share by Application (2016-2021)
Table 31. Global Wilson's Disease Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Wilson's Disease Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Wilson's Disease Drugs Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Wilson's Disease Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Wilson's Disease Drugs Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Wilson's Disease Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Wilson's Disease Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Wilson's Disease Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Wilson's Disease Drugs Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Wilson's Disease Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Wilson's Disease Drugs Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Wilson's Disease Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Wilson's Disease Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Wilson's Disease Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Wilson's Disease Drugs Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Wilson's Disease Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Wilson's Disease Drugs Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Wilson's Disease Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Wilson's Disease Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Wilson's Disease Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Wilson's Disease Drugs Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Wilson's Disease Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Wilson's Disease Drugs Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Wilson's Disease Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Wilson's Disease Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Wilson's Disease Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Wilson's Disease Drugs Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Wilson's Disease Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Wilson's Disease Drugs Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Wilson's Disease Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Wilson's Disease Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Wilson's Disease Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 63. Kadmon Holdings, Inc. Company Details
Table 64. Kadmon Holdings, Inc. Business Overview
Table 65. Kadmon Holdings, Inc. Wilson's Disease Drugs Product
Table 66. Kadmon Holdings, Inc. Revenue in Wilson's Disease Drugs Business (2016-2021) & (US$ Million)
Table 67. Kadmon Holdings, Inc. Recent Development
Table 68. Merck & Co. Company Details
Table 69. Merck & Co. Business Overview
Table 70. Merck & Co. Wilson's Disease Drugs Product
Table 71. Merck & Co. Revenue in Wilson's Disease Drugs Business (2016-2021) & (US$ Million)
Table 72. Merck & Co. Recent Development
Table 73. Teva Pharmaceutical Industries Limited Company Details
Table 74. Teva Pharmaceutical Industries Limited Business Overview
Table 75. Teva Pharmaceutical Industries Limited Wilson's Disease Drugs Product
Table 76. Teva Pharmaceutical Industries Limited Revenue in Wilson's Disease Drugs Business (2016-2021) & (US$ Million)
Table 77. Teva Pharmaceutical Industries Limited Recent Development
Table 78. Tsumura & Co. Company Details
Table 79. Tsumura & Co. Business Overview
Table 80. Tsumura & Co. Wilson's Disease Drugs Product
Table 81. Tsumura & Co. Revenue in Wilson's Disease Drugs Business (2016-2021) & (US$ Million)
Table 82. Tsumura & Co. Recent Development
Table 83. Valeant Pharmaceuticals International, Inc. Company Details
Table 84. Valeant Pharmaceuticals International, Inc. Business Overview
Table 85. Valeant Pharmaceuticals International, Inc. Wilson's Disease Drugs Product
Table 86. Valeant Pharmaceuticals International, Inc. Revenue in Wilson's Disease Drugs Business (2016-2021) & (US$ Million)
Table 87. Valeant Pharmaceuticals International, Inc. Recent Development
Table 88. VHB Life Sciences, Inc. Company Details
Table 89. VHB Life Sciences, Inc. Business Overview
Table 90. VHB Life Sciences, Inc. Wilson's Disease Drugs Product
Table 91. VHB Life Sciences, Inc. Revenue in Wilson's Disease Drugs Business (2016-2021) & (US$ Million)
Table 92. VHB Life Sciences, Inc. Recent Development
Table 93. Wilson Therapeutics AB (Alexion) Company Details
Table 94. Wilson Therapeutics AB (Alexion) Business Overview
Table 95. Wilson Therapeutics AB (Alexion) Wilson's Disease Drugs Product
Table 96. Wilson Therapeutics AB (Alexion) Revenue in Wilson's Disease Drugs Business (2016-2021) & (US$ Million)
Table 97. Wilson Therapeutics AB (Alexion) Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Wilson's Disease Drugs Market Share by Type: 2020 VS 2027
Figure 2. Hepatic Features
Figure 3. Neuropsychiatric Features
Figure 4. Ophthalmic Features
Figure 5. Others Features
Figure 6. Global Wilson's Disease Drugs Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Wilson's Disease Drugs Report Years Considered
Figure 11. Global Wilson's Disease Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Wilson's Disease Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Wilson's Disease Drugs Market Share by Regions: 2020 VS 2027
Figure 14. Global Wilson's Disease Drugs Market Share by Regions (2022-2027)
Figure 15. Global Wilson's Disease Drugs Market Share by Players in 2020
Figure 16. Global Top Wilson's Disease Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Wilson's Disease Drugs as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Wilson's Disease Drugs Revenue in 2020
Figure 18. Global Wilson's Disease Drugs Revenue Market Share by Type (2016-2021)
Figure 19. Global Wilson's Disease Drugs Revenue Market Share by Type (2022-2027)
Figure 20. North America Wilson's Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Wilson's Disease Drugs Market Share by Type (2016-2027)
Figure 22. North America Wilson's Disease Drugs Market Share by Application (2016-2027)
Figure 23. North America Wilson's Disease Drugs Market Share by Country (2016-2027)
Figure 24. United States Wilson's Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Wilson's Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Wilson's Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Wilson's Disease Drugs Market Share by Type (2016-2027)
Figure 28. Europe Wilson's Disease Drugs Market Share by Application (2016-2027)
Figure 29. Europe Wilson's Disease Drugs Market Share by Country (2016-2027)
Figure 30. Germany Wilson's Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Wilson's Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Wilson's Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Wilson's Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Wilson's Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Wilson's Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Wilson's Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Wilson's Disease Drugs Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Wilson's Disease Drugs Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Wilson's Disease Drugs Market Share by Region (2016-2027)
Figure 40. China Wilson's Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Wilson's Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Wilson's Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Wilson's Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Wilson's Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Wilson's Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Wilson's Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Wilson's Disease Drugs Market Share by Type (2016-2027)
Figure 48. Latin America Wilson's Disease Drugs Market Share by Application (2016-2027)
Figure 49. Latin America Wilson's Disease Drugs Market Share by Country (2016-2027)
Figure 50. Mexico Wilson's Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Wilson's Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Wilson's Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Wilson's Disease Drugs Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Wilson's Disease Drugs Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Wilson's Disease Drugs Market Share by Country (2016-2027)
Figure 56. Turkey Wilson's Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Wilson's Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Wilson's Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Kadmon Holdings, Inc. Revenue Growth Rate in Wilson's Disease Drugs Business (2016-2021)
Figure 60. Merck & Co. Revenue Growth Rate in Wilson's Disease Drugs Business (2016-2021)
Figure 61. Teva Pharmaceutical Industries Limited Revenue Growth Rate in Wilson's Disease Drugs Business (2016-2021)
Figure 62. Tsumura & Co. Revenue Growth Rate in Wilson's Disease Drugs Business (2016-2021)
Figure 63. Valeant Pharmaceuticals International, Inc. Revenue Growth Rate in Wilson's Disease Drugs Business (2016-2021)
Figure 64. VHB Life Sciences, Inc. Revenue Growth Rate in Wilson's Disease Drugs Business (2016-2021)
Figure 65. Wilson Therapeutics AB (Alexion) Revenue Growth Rate in Wilson's Disease Drugs Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---